Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro

Benzalkonium Chloride-Preserved Anti-Glaucomatous Eye Drops and Their Effect on Human Conjunctival Goblet Cells in vitro

Introduction: Most intraocular pressure (IOP)-lowering eye drops are preserved with benzalkonium chloride (BAK). This can increase side effects and decrease adherence. Particularly, damage to the mucin-producing conjunctival goblet cells may be an issue due to instability of the tear film. We aimed...

Full description

Bibliographic Details
Main Authors: Anne Hedengran, Xenia Begun, Olivia Müllertz, Zaynab Mouhammad, Rupali Vohra, Jeffrey Bair, Darlene A. Dartt, Barbara Cvenkel, Steffen Heegaard, Goran Petrovski, Miriam Kolko
Format: Article
Language:English
Published: Karger Publishers 2021-08-01
Series:Biomedicine Hub
Subjects:
goblet cells
glaucoma
benzalkonium chloride
anti-glaucomatous treatment
in vitro study
Online Access:https://www.karger.com/Article/FullText/517845

Internet

https://www.karger.com/Article/FullText/517845

Similar Items